Showing 581-590 of 23017 results for "".
Health Care Business 101 & Then Some
https://reachmd.com/programs/clinicians-roundtable/health-care-business-101-then-some/5181/Healthcare reform may bring more medical care services to patients, which means more and complex business for the nation's physicians. But are doctors prepared to be the best business people now and in the future for their patients? Dr. Wright Pinson, deputy vice chancellor for health affairs and CEBreaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
https://reachmd.com/programs/cme/breaking-the-line-moving-bispecific-antibodies-upstream-in-treating-multiple-myeloma/49265/Learn how early-line bispecific antibodies are reshaping multiple myeloma treatment, supported by emerging efficacy and safety data from key clinical trials.Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
https://reachmd.com/programs/cme/beyond-the-joint-cross-specialty-solutions-for-advancing-tgct-patient-care/36596/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
https://reachmd.com/programs/cme/advancing-clinical-expertise-in-celmods-transforming-multiple-myeloma-treatment/35631/This activity will cultivate familiarity with the emerging CELMoD treatment class poised to transform the management of newly-diagnosed and R/R MM. With a higher affinity for cereblon than their predecessors, CELMoDs represent a new, distinct generation of immunomodulatory drugs with the potential tFSGS in Practice: Patient-Centered Decision-Making
https://reachmd.com/programs/cme/fsgs-in-practice-patient-centered-decision-making/35713/Join our expert nephrology faculty and learn about practical strategies for improving your diagnostic skills and treatment selection in FSGS.Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
https://reachmd.com/programs/cme/modern-neuromodulation-vagus-nerve-stimulation-in-advancing-care-for-patients-with-drug-resistant-epilepsy-and-treatment-resistant-depression/33211/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
https://reachmd.com/programs/cme/lets-rewind-recognizing-nafldnash-in-the-primary-care-clinic/16020/Are you thinking NAFLD? As emerging therapies become available, PCPs need to be prepared to accurately identify patients at risk for NAFLD or NASH.Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
https://reachmd.com/programs/cme/strategic-excellence-mastering-the-expanding-attr-cm-therapeutic-landscape-in-pharmacy-practice/18124/Enhance pharmacists' expertise in managing ATTR-CM with advanced knowledge and clinical insights for this evolving landscape.How the Affordable Care Act is Faring: Updates from Capitol Hill
https://reachmd.com/programs/conversations-on-health-care/how-affordable-care-act-faring-updates-capitol-hill/7302/This week, hosts Mark Masselli and Margaret Flinter speak with Adriel Bettelheim, Managing Editor for Health at CQ Roll Call/Economist which boasts the largest press corps on Capitol Hill. Mr. Bettelheim discusses the legislative landscape impacting the Affordable Care Act as well as the emerging paIT Audits and Compliance in Medical Care
https://reachmd.com/programs/primary-care-today/it-audits-and-compliance-in-medical-care/6949/Dr. Brian McDonough is joined by Torpey White, Director of the Governance, Risk and Compliance Group. Their discussion will focus on compliance, as well as how to utilize electronic technology in order to benefit your patients. Mr. White will also touch on the HIPAA privacy rule, accepting credit ca